BioPharma Credit (LON:BPCR) Shares Down 0.2% – Should You Sell?

BioPharma Credit (LON:BPCRGet Free Report)’s share price dropped 0.2% during mid-day trading on Wednesday . The company traded as low as GBX 0.91 and last traded at GBX 0.91. Approximately 627,285 shares were traded during trading, a decline of 41% from the average daily volume of 1,059,167 shares. The stock had previously closed at GBX 0.91.

BioPharma Credit Trading Down 0.2%

The firm’s 50 day moving average price is GBX 0.90 and its 200-day moving average price is GBX 0.90. The company has a market cap of £10.25 million, a P/E ratio of 0.09 and a beta of 0.22.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Featured Stories

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.